IP and Patent Strategies for MedTech Companies: Building Device and/or Software

IP can often become the bedrock for assessing a medical device or software-as-a-medical device's valuation. Though many founders realize its importance, a foundational knowledge of how the process works, how to select the right legal partner, how to evaluate your innovation's IP potential, and how counterparties might value your IP portfolio’s merit is often left in the hands of lawyers without founders being given enough context to fully understand their decisions and the ramifications.

In this webinar, Martin Gomez, a Partner at Goodwin Procter LLP will guide us through the landscape of patentability challenges and strategies to safeguard your innovations. Whether you are a startup or an established company in the MedTech space, this webinar will equip you with the knowledge to navigate the complex world of intellectual property and frame your understanding to help maximize your innovation's potential.

Key takeaways:

• Learn how important IP really is

• Have the skills to evaluate your potential legal counsel

• Understand what IP is the most important to protect and how to evaluate your innovations IP portfolio potential

• Have realistic timeline expectations

• Appreciate how AI/ML has created protectable opportunity

Martin Gomez is a partner in Goodwin’s Technology and Life Sciences Business Unit, specializing in intellectual property matters, and is a co-leader of the Firm’s MedTech and Artificial Intelligence practice groups. Martin focuses his practice on advising technology and life sciences companies of all sizes (including startups), and their investors, in corporate and especially intellectual property matters throughout the business life cycle, including new company formation, IP protection, fundraising, strategic transactions, and exits.